Isatin, an endogenous MAO inhibitor, as a new biological modulator

CNS Drug Reviews

Volumn 5, Issue 4, 1999, Pages 331-346

  Hamaue, Naoya ^a   Minami, Masaru ^a   Hirafuji, Masahiko ^a   Terado, Mutsuko ^a   Machida, Minoru ^a   Yamazaki, Noriko ^b   Yoshioka, Mitsuhiro ^b   Ogata, Akihiko ^b   Tashiro, Kunio ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Biological modulator; Endogenous MAO inhibitor; Isatin; Parkinson's disease; SHRSP; Striatal acetylcholine level; Striatal dopamine level

Indexed keywords

ACETYLCHOLINE; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; ISATIN; TRIBULIN;

ANTICONVULSANT ACTIVITY; CORPUS STRIATUM; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; HYPERTENSION; NEUROPROTECTION; PARKINSON DISEASE; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 0033490635     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.1999.tb00109.x     Document Type: Review

References (65)

1. Anholt RR. Mitochondrial benzodiazepine receptors as potential modulators of intermediary metabolism. Trends Pharmacol Sci 1986;6:506-511.
2. Armando I, Barontini M, Levin G, et al. Exercise increases endogenous urinary monoamine oxidase benzodiazepine receptor ligand inhibitory activity in normal children. J Auton Nerv Syst 1984;11:95-100.
3. Armando I, Levin G, Barontini M. Stress increases endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in rat tissues. J Neural Transm 1988;71:29-37.
4. Bansal RC, Kaur P, Kiran R. Mode of interaction of isatin with rat liver alkaline phosphatase. Res Bull (Science) PU, Chandigarh 1988;39:71-76.
5. Basile AS, Skolnick P. Tissue specific regulation of "peripheral-type" benzodiazepine receptor density after chemical sympathectomy. Life Sci 1988;42:273-283.
6. Battacharya SK, Acharya SB. Further investigations on the anxiogenic effects of isatin. Biogen Amines 1993;9:453-463.
7. Battacharya SK, Chakrabarti A, Glover V, et al. Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat. Neuropsychopharmacology 1996;15:199-206.
8. Battacharya SK, Clow A, Przyborowska A, et al. Effects of aromatic amino acids, pentylenetetrazol and yohimbine on isatin and tribulin activity in rat brain. Neurosci Lett 1991;132:44-46.
9. Battacharya ST, Glover V, Sandler M, et al. Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: Effects of L-dopa and ethanol. Biol Psychiatry 1982;17:829-836.
10. Blaschko H. Amine oxidase. In: Boyer PD, Lardy H, and Myrback K, eds. The enzymes. Vol. 8, 3rd ed. New York: Academic Press, 1973:337-351.
11. Chocholova L, Kolinova M. Effect of isatin on audiogenic seizures in rats and its relationship to electrographic and behavioral phenomena. Physiol Bohemoslov 1979;28:495-502.
12. Chocholova L, Kolinova M. Effect of isatin (2,3 dioxyindoline) on physiological and pathological electrographic manifestations of vigilance. Physiol Bohemoslov 1981;30:129-137.
13. Clow A, Glover V, Armando I, et al. New endogenous benzodiazepine receptor ligand in human urine: Identity with endogenous MAO inhibitor? Life Sci 1983;33:735-741.
14. Clow A, Glover V, Sandler M, et al. Increased urinary tribulin output in generalized anxiety disorder. Psychopharmacology 1988;95:378-380.
15. Clow A, Glover V, Weg MW, et al. Urinary catecholamine metabolite and tribulin output during lactate infusion. Br J Psychiatry 1988;152:122-126.
16. Clow A, Hussain T, Glover V. et al. Pergolide can induce soluble superoxide dismutase in rat striata. J Neural Transm 1992;90:27-31.
17. Elsworth JD, Dewar D, Glover V, et al. Purification and characterization of tribulin, an endogenous inhibitor of monoamine oxidase and benzodiazepine receptor binding. J Neural Transm 1986;67:45-56.
18. Glover V, Battacharya SK, Sandler M. Isatin - a new biological factor. Ind J Exp Biol 1991;29:1-5.
19. Glover V, Clow A, Sandler M. Effects of dopaminergic drugs on superoxide dismutase: Implications for senescence. J Neural Transm (Suppl) 1993;40:37-45.
20. Glover V, Halket JM, Watkins PJ, et al. Isatin: Identity with the purified endogenous monoamine oxidase inhibitor tribulin. J Neurochem 1988;51:656-659.
21. Glover V, Medvedev A, Sandler M. Isatin is a potent endogenous antagonist of guanylate cyclase-coupled atrial natriuretic peptide receptors. Life Sci 1995;57:2073-2079.
22. Glover V, Reveley MA, Sandler M. A monoamine oxidase inhibitor in human urine. Biochem Pharmacol 1980;29:467-470.
23. Gorell JM, Czarnecki B. Pharmacological evidence for direct dopaminergic regulation of striatal acetylcholine release. Life Sci 1986;38:2239-2246.
24. Hamaue N, Minami M, Hirafuji M, et al. Significance of isatin, an endogenous MAO inhibitor, on blood pressure control and monoamine levels. Biogen Amines 1996;12:395-405.
25. Hamaue N, Minami M, Kanamaru Y, et al. Endogenous monoamine oxidate (MAO) inhibitor (tribulin-like activity) in the brain and urine of stroke-prone SHR. Biogen Amines 1992;8:401-412.
26. Hamaue N, Minami M, Kanamaru Y, et al. Identification of isatin, an endogenous MAO inhibitor, in the brain of stroke-prone SHR. Biogen Amines 1994;10:99-110.
27. Hamaue N, Yamazaki N, Minami M, et al. Determination of isatin, an endogenous monoamine oxidase inhibitor, in urine and tissues of rats by HPLC. Gen Pharmacol 1998;30:387-391.
28. Hamaue N, Yamazaki N, Minami M, et al. Effects of isatin, an endogenous MAO inhibitor, on acetylcholine and dopamine levels in the rat striatum. Biogen Amines 1999;15:367-377.
29. Hota D, Acharya SB. Studies on peripheral actions of isatin. Ind J Exp Biol 1994;32:710-717.
30. Hoehn MM, Yarh MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-442.
31. Imperato A, Obinu MC, Casu A, et al. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D, receptors. J Pharmacol Exp Ther 1993;266:557-562.
32. Jarman J, Przylorowska A, Glover Y, et al. Urinary output of endogenous monoamine oxidase inhibitor and isatin during acute migraine attack. J Neural Transm Gen Sect 1990;84:129-134.
33. Knoll J. The facilitation of dopaminergic activity in the aged brain by (-)-deprenyl. A proposal for strategy to improve the quality of life in senescence. Mech Aging Dev 1985;30:109-122.
34. Kumar P, Bansal RC, Mahmood A. Isatin, an inhibitor of acetylcholinesterase activity in rat brain. Biogen Amines 1993;9:281-289.
35. Kumar P, Dani HM, Trehan S. Effect of isatin testicular hyaluronidase. Ind J Exp Biol 1977;15:655-656.
36. Lehmann J, Langer SZ. The striatal cholinergic interneuron: Synaptic target of dopaminergic terminals? Neuroscience 1983;10:1105-1120.
37. Matsumoto M, Togashi H, Yoshioka M, et al. Simultaneous high-performance liquid chromatographic determination of norepinephrine, serotonin, acetylcholine and their metabolites in the cerebrospinal fluid of anaesthetized normotensive rats. J Chromatogr 1990;52:1-10.
38. McIntyre IM, Norman TR. Serotonergic effects of isatin: An endogenous MAO inhibitor related to tribulin. J Neural Transm 1990;79:35-10.
39. Medvedev AE, Clow A. Sandler M, et al. Isatin: A link between natriuretic peptides and monoamines? J Biochem Pharmacol 1996;52:385-391.
40. 2-receptor sensitive voltage-operated calcium channels in the guinea pig heart. Life Sci 1986;39:329-339.
41. Milgram NW, Racine RJ, Nellis P, et al. Maintenance on L-deprenyl prolongs life in aged male rats. Life Sci 1990;47:415-420.
42. Minami M, Senjo M, Togashi H, et al. Kidney glutathione S-transferase activity and kidney monoamine oxidase activity in stroke cases of SHRSP. Biogen Amines 1988;5:517-526.
43. Muller M, Schramek J. Combined application of propranolol and local anesthetics: Enhanced anticonvulsant action. Biomed Biochim Acta 1989;4:333-336.
44. Nilsson OG, Leanza G, Bjkölund A. Acetylcholine release in the hippocampus: Regulation by monoaminergic afferents as assessed by m vivo microdialysis. Brain Res 1992;584:132-140.
45. Ogata A, Tashiro K, Nukuzuma S, et al. A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol 1997;3:141-147.
46. Ohue T, Koshimura K, Akiyama Y, et al. Regulation of acetylcholine release in vivo from rat hippocampus by monoamines as revealed by novel column-switching HPLC with electrochemical detection. Brain Res 1992;572:340-344.
47. Oxenkrug G, McIntyre I. Stress-induced synthesis of melatonin: Possible involvement of the endogenous monoamine oxidase inhibitor (tribulin). Life Sci 1985;37:1743-1746.
48. Parvez H, Parvez S. The effects of metopirone and adrenalectomy on the regulation of the enzymes monoamine oxidase and catechol-O-methyl transferase in different brain regions. J Neurochem 1973;20:1011-1020.
49. Paxinos G, Wason C. The Rat Brain in Streotaxic Coordinates. 2nd ed. New York: Academic Press Inc., 1980.
50. Peturson H, Bhattacharya SK, Glover V, et al. Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. Br J Psychiatry 1982;140:7-10.
51. Sandler M. The emergence of tribulin. Trends Pharmacol Sci 1982;3:471-472.
52. Satyan KS, Rai A, Jaiswal AK, et al. Isatin, a putative anxiogenic endocoid, induces memory dysfunction in rats. Ind J Exp Biol 1995;33:576-579.
53. 1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci 1992;31:2883-2890.
54. Sethy VH, van Woert MH. Regulation of striatal acetylcholine concentration by dopamine receptors. Nature 1974;251:529-530.
55. Singh B, Sharma R, Sareen K, et al. Isatin enzyme interaction V. Activation of rat liver acid phosphatase. Enzyme 1977;22:256-261.
56. Stadler H, Lloyd KG, Gadea-Ciria M, et al. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res 1973;55:476-480.
57. Stoof JC, Drukarch B, DeBoer P, et al. Regulation of the activity of striatal cholinergic neurons by L-DOPA. Neuroscience 1992;47:755-770.
58. Susheela I, Singh B, Dani HM, et al. Enzyme inhibition by isatin I. Inhibition of rat liver xanthine oxidase. Enzymology 1969;37:325-334.
59. Tozawa Y, Ueki A, Manabe S, et al. Stress-induced increase in urinary isatin excretion in rats-reversal by both dexamethasone and α-methyl-p-tyrosine. Biochem Pharmacol 1998;56:1041-1046.
60. Ueki A, Willoughby J, Glover V, et al. Endogenous urinary monoamine oxidase inhibitor excretion in Parkinson's disease and other neurological disorders. J Neural Transm 1989;1:263-268.
61. Watkins P, Clow A, Glover V, et al. Isatin, regional distribution in rat brain and tissues. Neurochem Int 1990;17:321-323.
62. Wedzong K, Limberger N, Spath L, et al. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D, receptor. Naunyn-Schmiedeberg's Arch Pharmacol 1988;338:250-255.
63. Wilkins MR, Nunez DJ, Wharton J. The natriuretic peptide family: Turning hormones into drugs. J Endocrinol 1993;137:347-359.
64. Yang HYT, Neff NH. The monoamine oxidases of brain: Selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. J Pharmacol Exp Ther 1974;189:733-740.
65. Yumiler AT. The effect of isatin (tribulin) on metabolism of indoles in the rat brain and pineal: In vitro and in vivo studies. Neurochem Res 1990;15:95-100.